Cargando…

Evaluation of a simplified optimizer for MR‐guided adaptive RT in case of pancreatic cancer

PURPOSE: Magnetic resonance‐guided adaptive radiotherapy (MRgART) is considered a promising resource for pancreatic cancer, as it allows to online modify the dose distribution according to daily anatomy. This study aims to compare the dosimetric performance of a simplified optimizer implemented on a...

Descripción completa

Detalles Bibliográficos
Autores principales: Cusumano, Davide, Boldrini, Luca, Menna, Sebastiano, Teodoli, Stefania, Placidi, Elisa, Chiloiro, Giuditta, Placidi, Lorenzo, Greco, Francesca, Stimato, Gerardina, Cellini, Francesco, Valentini, Vincenzo, Azario, Luigi, De Spirito, Marco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6753732/
https://www.ncbi.nlm.nih.gov/pubmed/31444952
http://dx.doi.org/10.1002/acm2.12697
_version_ 1783452950137405440
author Cusumano, Davide
Boldrini, Luca
Menna, Sebastiano
Teodoli, Stefania
Placidi, Elisa
Chiloiro, Giuditta
Placidi, Lorenzo
Greco, Francesca
Stimato, Gerardina
Cellini, Francesco
Valentini, Vincenzo
Azario, Luigi
De Spirito, Marco
author_facet Cusumano, Davide
Boldrini, Luca
Menna, Sebastiano
Teodoli, Stefania
Placidi, Elisa
Chiloiro, Giuditta
Placidi, Lorenzo
Greco, Francesca
Stimato, Gerardina
Cellini, Francesco
Valentini, Vincenzo
Azario, Luigi
De Spirito, Marco
author_sort Cusumano, Davide
collection PubMed
description PURPOSE: Magnetic resonance‐guided adaptive radiotherapy (MRgART) is considered a promising resource for pancreatic cancer, as it allows to online modify the dose distribution according to daily anatomy. This study aims to compare the dosimetric performance of a simplified optimizer implemented on a MR‐Linac treatment planning system (TPS) with those obtained using an advanced optimizer implemented on a conventional Linac. METHODS: Twenty patients affected by locally advanced pancreatic cancer (LAPC) were considered. Gross tumor volume (GTV) and surrounding organ at risks (OARs) were contoured on the average 4DCT scan. Planning target volume was generated from GTV by adding an isotropic 3 mm margin and excluding overlap areas with OARs. Treatment plans were generated by using the simple optimizer for the MR‐Linac in intensity‐modulated radiation therapy (IMRT) and the advanced optimizer for conventional Linac in IMRT and volumetric modulated arc therapy (VMAT) technique. Prescription dose was 40 Gy in five fractions. The dosimetric comparison was performed on target coverage, dosimetric indicators, and low dose diffusion. RESULTS: The simplified optimizer of MR‐Linac generated clinically acceptable plans in 80% and optimal plans in 55% of cases. The number of clinically acceptable plans obtained using the advanced optimizer of the conventional Linac with IMRT was the same of MR‐Linac, but the percentage of optimal plans was higher (65%). Using the VMAT technique, it is possible to obtain clinically acceptable plan in 95% and optimal plans in 90% of cases. The advanced optimizer combined with VMAT technique ensures higher target dose homogeneity and minor diffusion of low doses, but its actual optimization time is not suitable for MRgART. CONCLUSION: Simplified optimization solutions implemented in the MR‐Linac TPS allows to elaborate in most of cases treatment plans dosimetrically comparable with those obtained by using an advanced optimizer. A superior treatment plan quality is possible using the VMAT technique that could represent a breakthrough for the MRgART if the modern advancements will lead to shorter optimization times.
format Online
Article
Text
id pubmed-6753732
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-67537322019-09-23 Evaluation of a simplified optimizer for MR‐guided adaptive RT in case of pancreatic cancer Cusumano, Davide Boldrini, Luca Menna, Sebastiano Teodoli, Stefania Placidi, Elisa Chiloiro, Giuditta Placidi, Lorenzo Greco, Francesca Stimato, Gerardina Cellini, Francesco Valentini, Vincenzo Azario, Luigi De Spirito, Marco J Appl Clin Med Phys Radiation Oncology Physics PURPOSE: Magnetic resonance‐guided adaptive radiotherapy (MRgART) is considered a promising resource for pancreatic cancer, as it allows to online modify the dose distribution according to daily anatomy. This study aims to compare the dosimetric performance of a simplified optimizer implemented on a MR‐Linac treatment planning system (TPS) with those obtained using an advanced optimizer implemented on a conventional Linac. METHODS: Twenty patients affected by locally advanced pancreatic cancer (LAPC) were considered. Gross tumor volume (GTV) and surrounding organ at risks (OARs) were contoured on the average 4DCT scan. Planning target volume was generated from GTV by adding an isotropic 3 mm margin and excluding overlap areas with OARs. Treatment plans were generated by using the simple optimizer for the MR‐Linac in intensity‐modulated radiation therapy (IMRT) and the advanced optimizer for conventional Linac in IMRT and volumetric modulated arc therapy (VMAT) technique. Prescription dose was 40 Gy in five fractions. The dosimetric comparison was performed on target coverage, dosimetric indicators, and low dose diffusion. RESULTS: The simplified optimizer of MR‐Linac generated clinically acceptable plans in 80% and optimal plans in 55% of cases. The number of clinically acceptable plans obtained using the advanced optimizer of the conventional Linac with IMRT was the same of MR‐Linac, but the percentage of optimal plans was higher (65%). Using the VMAT technique, it is possible to obtain clinically acceptable plan in 95% and optimal plans in 90% of cases. The advanced optimizer combined with VMAT technique ensures higher target dose homogeneity and minor diffusion of low doses, but its actual optimization time is not suitable for MRgART. CONCLUSION: Simplified optimization solutions implemented in the MR‐Linac TPS allows to elaborate in most of cases treatment plans dosimetrically comparable with those obtained by using an advanced optimizer. A superior treatment plan quality is possible using the VMAT technique that could represent a breakthrough for the MRgART if the modern advancements will lead to shorter optimization times. John Wiley and Sons Inc. 2019-08-24 /pmc/articles/PMC6753732/ /pubmed/31444952 http://dx.doi.org/10.1002/acm2.12697 Text en © 2019 The Authors. Journal of Applied Clinical Medical Physics published by Wiley Periodicals, Inc. on behalf of American Association of Physicists in Medicine. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Radiation Oncology Physics
Cusumano, Davide
Boldrini, Luca
Menna, Sebastiano
Teodoli, Stefania
Placidi, Elisa
Chiloiro, Giuditta
Placidi, Lorenzo
Greco, Francesca
Stimato, Gerardina
Cellini, Francesco
Valentini, Vincenzo
Azario, Luigi
De Spirito, Marco
Evaluation of a simplified optimizer for MR‐guided adaptive RT in case of pancreatic cancer
title Evaluation of a simplified optimizer for MR‐guided adaptive RT in case of pancreatic cancer
title_full Evaluation of a simplified optimizer for MR‐guided adaptive RT in case of pancreatic cancer
title_fullStr Evaluation of a simplified optimizer for MR‐guided adaptive RT in case of pancreatic cancer
title_full_unstemmed Evaluation of a simplified optimizer for MR‐guided adaptive RT in case of pancreatic cancer
title_short Evaluation of a simplified optimizer for MR‐guided adaptive RT in case of pancreatic cancer
title_sort evaluation of a simplified optimizer for mr‐guided adaptive rt in case of pancreatic cancer
topic Radiation Oncology Physics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6753732/
https://www.ncbi.nlm.nih.gov/pubmed/31444952
http://dx.doi.org/10.1002/acm2.12697
work_keys_str_mv AT cusumanodavide evaluationofasimplifiedoptimizerformrguidedadaptivertincaseofpancreaticcancer
AT boldriniluca evaluationofasimplifiedoptimizerformrguidedadaptivertincaseofpancreaticcancer
AT mennasebastiano evaluationofasimplifiedoptimizerformrguidedadaptivertincaseofpancreaticcancer
AT teodolistefania evaluationofasimplifiedoptimizerformrguidedadaptivertincaseofpancreaticcancer
AT placidielisa evaluationofasimplifiedoptimizerformrguidedadaptivertincaseofpancreaticcancer
AT chiloirogiuditta evaluationofasimplifiedoptimizerformrguidedadaptivertincaseofpancreaticcancer
AT placidilorenzo evaluationofasimplifiedoptimizerformrguidedadaptivertincaseofpancreaticcancer
AT grecofrancesca evaluationofasimplifiedoptimizerformrguidedadaptivertincaseofpancreaticcancer
AT stimatogerardina evaluationofasimplifiedoptimizerformrguidedadaptivertincaseofpancreaticcancer
AT cellinifrancesco evaluationofasimplifiedoptimizerformrguidedadaptivertincaseofpancreaticcancer
AT valentinivincenzo evaluationofasimplifiedoptimizerformrguidedadaptivertincaseofpancreaticcancer
AT azarioluigi evaluationofasimplifiedoptimizerformrguidedadaptivertincaseofpancreaticcancer
AT despiritomarco evaluationofasimplifiedoptimizerformrguidedadaptivertincaseofpancreaticcancer